Integrative Metabolomic and Metallomic Analysis in a Case-Control Cohort With Parkinson's Disease

被引:17
|
作者
Lucio, Marianna [1 ]
Willkommen, Desiree [1 ]
Schroeter, Michael [2 ]
Sigaroudi, Ali [3 ,4 ]
Schmitt-Kopplin, Philippe [1 ,5 ]
Michalke, Bernhard [1 ]
机构
[1] Helmholtz Zentrum Munchen, Analyt BioGeoChem, Neuherberg, Germany
[2] Uniklin Koln, Klin & Poliklin Neurol, Cologne, Germany
[3] Univ Spital Zurich, Klin Klin Pharmakol & Toxikol, Zurich, Switzerland
[4] Uniklin Koln, Zentrum Pharmakol, Inst Pharmakol 1, Cologne, Germany
[5] Tech Univ Munich, Life Sci Ctr Weihenstephan, Chair Analyt Food Chem, Munich, Germany
来源
FRONTIERS IN AGING NEUROSCIENCE | 2019年 / 11卷
关键词
data integration; metabolomics; metallomics; Block-sPLS-DA; Parkinson's disease; CEREBROSPINAL-FLUID; MANGANESE EXPOSURE; NEURODEGENERATION; PREVALENCE; COMPONENT; METALS; COPPER; SERUM; IRON;
D O I
10.3389/fnagi.2019.00331
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Parkinson's disease (PD) is a neurodegenerative disease with a complex etiology. Several factors are known to contribute to the disease onset and its progression. However, the complete underlying mechanisms are still escaping our understanding. To evaluate possible correlations between metabolites and metallomic data, in this research, we combined a control study measured using two different platforms. For the different data sources, we applied a Block Sparse Partial Least Square Discriminant Analysis (Block-sPLS-DA) model that allows for proving their relation, which in turn uncovers alternative influencing factors that remain hidden otherwise. We found two groups of variables that trace a strong relationship between metallomic and metabolomic parameters for disease development. The results confirmed that the redox active metals iron (Fe) and copper (Cu) together with fatty acids are the major influencing factors for the PD. Additionally, the metabolic waste product p-cresol sulfate and the trace element nickel (Ni) showed up as potentially important factors in PD. In summary, the data integration of different types of measurements emphasized the results of both stand-alone measurements providing a new comprehensive set of information and interactions, on PD disease, between different variables sources.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Smoking and Parkinson's disease: A case-control study in Germany
    Hellenbrand, W
    Seidler, A
    Robra, BP
    Vieregge, P
    Oertel, WH
    Joerg, J
    Nischan, P
    Schneider, E
    Ulm, G
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1997, 26 (02) : 328 - 339
  • [22] Diagnostic metabolomic profiling of Parkinson's disease biospecimens
    LeWitt, Peter A.
    Li, Jia
    Wu, Kuan-Han
    Lu, Mei
    NEUROBIOLOGY OF DISEASE, 2023, 177
  • [23] Treatment Responsiveness of Motor Features in Parkinson's Disease: A Matched Case-Control Analysis
    Macleod, Angus D.
    Counsell, Carl E.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2020, 7 (01): : 45 - 51
  • [24] Characterization of Gastrointestinal Symptom Type and Severity in Parkinson's Disease: A Case-Control Study in an Australian Cohort
    Kenna, Jade E.
    Bakeberg, Megan C.
    Gorecki, Anastazja M.
    Chin Yen Tay, Alfred
    Winter, Samantha
    Mastaglia, Frank L.
    Anderton, Ryan S.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2021, 8 (02): : 245 - 253
  • [25] Association of circulating manganese levels with Parkinson's disease: A meta-analysis
    Du, Ke
    Liu, Ming-Yan
    Pan, Yan-Zhu
    Zhong, Xin
    Wei, Min-Jie
    NEUROSCIENCE LETTERS, 2018, 665 : 92 - 98
  • [26] Insights on Genetic and Environmental Factors in Parkinson's Disease from a Regional Swedish Case-Control Cohort
    Brolin, Kajsa
    Bandres-Ciga, Sara
    Blauwendraat, Cornelis
    Widner, Hakan
    Odin, Per
    Hansson, Oskar
    Puschmann, Andreas
    Swanberg, Maria
    JOURNAL OF PARKINSONS DISEASE, 2022, 12 (01) : 153 - 171
  • [27] Outlining a Population (at Risk) of Parkinson's Disease: Evidence from a Case-Control Study
    Schirinzi, Tommaso
    Martella, Giuseppina
    D'Elia, Alessio
    Di Lazzaro, Giulia
    Imbriani, Paola
    Madeo, Graziella
    Monaco, Leonardo
    Maltese, Marta
    Pisani, Antonio
    PARKINSONS DISEASE, 2016, 2016
  • [28] Bell's Palsy Preceding Parkinson's Disease: A Case-Control Study
    Savica, Rodolfo
    Bower, James H.
    Maraganore, Demetrius M.
    Grossardt, Brandon R.
    Rocca, Walter A.
    MOVEMENT DISORDERS, 2009, 24 (10) : 1530 - 1533
  • [29] Dopamine agonists and ischemic complications in Parkinson's disease: a nested case-control study
    Arbouw, Maurits E. L.
    Movig, Kris L. L.
    Guchelaar, Henk-Jan
    Neef, Cees
    Egberts, Toine C. G.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (01) : 83 - 88
  • [30] Parkinson's disease and cerebrovascular disease: is there a link? A neurosonological case-control study
    Marsala, Sandro Zambito
    Gioulis, Manuela
    Pistacchi, Michele
    Lo Cascio, Cecilia
    NEUROLOGICAL SCIENCES, 2016, 37 (10) : 1707 - 1711